How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,609 results for

Paracentesis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis. (PubMed)

Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis. Plasma volume expanders are used in connection to paracentesis in people with cirrhosis to prevent reduction of effective plasma volume, which may trigger deleterious effect on haemodynamic balance, and increase morbidity and mortality. Albumin is considered the standard product against which no plasma expansion or other plasma expanders, e.g. other colloids (polygeline , dextrans, hydroxyethyl (...) expander for paracentesis in people with cirrhosis and large ascites.We searched the Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, LILACS, CNKI, VIP, Wanfang, Science Citation Index Expanded, and Conference Proceedings Citation Index until January 2019. Furthermore, we searched FDA, EMA, WHO (last search January 2019), www.clinicaltrials.gov/, and www.controlled-trials.com/ for ongoing trials.Randomised clinical

2019 Cochrane

2. Albumin for Patients With SBP or Large-Volume Paracentesis

Albumin for Patients With SBP or Large-Volume Paracentesis Emergency Medicine > Journal Club > Archive > March 2015 Toggle navigation March 2015 Albumin for Patients With SBP or Large-Volume Paracentesis Vignette You are caring for a fifty year old gentleman with a history of non‐alcoholic steatohepatitis with cirrhosis who presents to the emergency department (ED) with increased abdominal distension, shortness of breath, and fevers. His abdomen is distended and tense with mild diffuse (...) tenderness. His temp is 38.7 C, BP is 103/60, HR is 89, and SpO2 is 99% on room air. You check his labs and find a WBC of 13.4, baseline anemia, a creatinine of 1.2, and an INR of 1.4. His chest x-ray reveals small lung volumes without infiltrates or pulmonary edema. A bedside ultrasound reveals a large amount of ascites. You decide to perform both a therapeutic paracentesis to relieve pressure on his diaphragm and improve his respiratory complaints, and send fluid to the lab for cell count, differential

2015 Washington University Emergency Medicine Journal Club

3. Paracentesis for the Removal of Peritoneal Fluid

Paracentesis for the Removal of Peritoneal Fluid TITLE: Paracentesis for the Removal of Peritoneal Fluid: Guidelines DATE: 29 January 2014 RESEARCH QUESTIONS 1. What are the evidence-based guidelines regarding the amount of fluid that can safely be drained by paracentesis? 2. What are the evidence-based guidelines regarding the maintenance of indwelling paracentesis catheters? KEY MESSAGE One systematic review and two evidence-based guidelines were identified regarding the amount of fluid (...) that can safely be drained or the maintenance of indwelling catheters in adult patients undergoing paracentesis. METHODS A limited literature search was conducted on key resources including PubMed, The Cochrane Library (2014, Issue 1), University of York Centre for Reviews and Dissemination (CRD) databases, ECRI (Health Devices Gold), Canadian and major international health technology agencies, as well as a focused Internet search. Methodological filters were applied to limit retrieval to health

2014 Canadian Agency for Drugs and Technologies in Health - Rapid Review

5. Computerized Tomography-Guided Paracentesis: An Effective Alternative to Bedside Paracentesis? (PubMed)

Computerized Tomography-Guided Paracentesis: An Effective Alternative to Bedside Paracentesis? Ascites remains the most common cause of hospitalization among patients with decompensated cirrhosis. Paracentesis is a relatively safe procedure with low complication rates. Computerized tomography (CT)-guided therapeutic paracentesis could be a safe and effective alternative to unaided or aided (ultrasonogram-guided) bedside paracentesis. In this retrospective study, we aimed to compare the efficacy (...) , safety, and cost-effectiveness of CT-guided paracentesis with bedside paracentesis.The period of study was from 2002 to 2012. All patients with cirrhosis who underwent therapeutic paracentesis were included in the study. These patients were divided into two groups. Group I consisted of patients who underwent CT-guided pigtail catheter insertion with ascitic fluid drainage. Group II consisted of patients who underwent beside therapeutic paracentesis after localization of fluid either by physical

Full Text available with Trip Pro

2016 Journal of clinical medicine research

6. Recommendations on the Use of Ultrasound Guidance for Adult Abdominal Paracentesis: A Position Statement of the Society of Hospital Medicine. (PubMed)

Recommendations on the Use of Ultrasound Guidance for Adult Abdominal Paracentesis: A Position Statement of the Society of Hospital Medicine. 1. We recommend that ultrasound guidance should be used for paracentesis to reduce the risk of serious complications, the most common being bleeding. 2. We recommend that ultrasound guidance should be used to avoid attempting paracentesis in patients with an insufficient volume of intraperitoneal free fluid to drain. 3. We recommend that ultrasound (...) guidance should be used with paracentesis to improve the success rates of the overall procedure. 4. We recommend that ultrasound should be used to assess the volume and location of intraperitoneal free fluid to guide clinical decision making of where paracentesis can be safely performed. 5. We recommend that ultrasound should be used to identify a needle insertion site based on size of the fluid collection, thickness of the abdominal wall, and proximity to abdominal organs. 6. We recommend

Full Text available with Trip Pro

2019 Journal of Hospital Medicine

7. Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study. (PubMed)

Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study. Albumin infusion reduces the incidence of postparacentesis circulatory dysfunction among patients with cirrhosis and tense ascites compared with no treatment. Less costly treatment alternatives such as vasoconstrictors have been investigated, but the results are controversial. Midodrine, an oral α1-adrenergic agonist, increases effective (...) circulating blood volume and renal perfusion by increasing systemic and splanchnic blood pressure. Our aim is to assess whether or not morbidity in terms of renal dysfunction, hyponatremia, systemic, or portal hemodynamics derangement or mortality differed in patients receiving albumin versus midodrine.Seventy-five patients with cirrhosis and refractory ascites were randomized to receive albumin infusion, oral midodrine for 2 days, or oral midodrine for 30 days after therapeutic large volume paracentesis

2019 European journal of gastroenterology & hepatology

8. Paracentesis for the removal of peritoneal fluid: guidelines

Paracentesis for the removal of peritoneal fluid: guidelines Paracentesis for the removal of peritoneal fluid: guidelines Paracentesis for the removal of peritoneal fluid: guidelines CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Paracentesis for the removal of peritoneal fluid: guidelines. Ottawa: Canadian Agency for Drugs (...) and Technologies in Health (CADTH). Rapid Response - Summary of Abstracts. 2014 Authors' conclusions One systematic review and two evidence-based guidelines were identified regarding the amount of fluid that can safely be drained or the maintenance of indwelling catheters in adult patients undergoing paracentesis. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Paracentesiss; Peritoneal Cavity Language Published English Country of organisation Canada Province or state Ontario

2014 Health Technology Assessment (HTA) Database.

9. Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer

Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer Harding V, Fenu E, Medani H, Shaboodien R, Ngan S, Li HK, Burt R, Diamantis N, Tuthill M (...) , Blagden S, Gabra H, Urch CE, Moser S, Agarwal R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The aim was to asses the cost-effectiveness of day-patient paracentesis, compared with in-patient paracentesis, for women with ovarian cancer

Full Text available with Trip Pro

2013 NHS Economic Evaluation Database.

10. Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study. (PubMed)

Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study. To investigate the effects of intravitreal injection of bevacizumab (IVB) with or without anterior chamber paracentesis on intraocular pressure (IOP) and peripapillary retinal nerve fiber layer (PRNFL) thickness.In this prospective randomized clinical trial, 90 eyes with center involving diabetic (...) macular edema or wet type age-related macular degeneration (AMD) were randomly assigned to receive IVB either without (group A) or with (group B) anterior chamber paracentesis. IOP was measured before and within 2 min, 30 min, 24 hours and 3 months after injections. Peripapillary spectral-domain optical coherence tomography (SD-OCT) was performed before and 3 months after injections.Mean IOP changes 2 minutes, 30 minutes, 24 hours, and 3 months after injections were 26.4 ± 5.7 mmHg (P < 0.001), 6.5

2018 Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

11. Corrigendum to "Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study" [J Hepatol 67 (2017) 940-949]. (PubMed)

Corrigendum to "Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study" [J Hepatol 67 (2017) 940-949]. 29395458 2019 03 07 1600-0641 68 3 2018 03 Journal of hepatology J. Hepatol. Corrigendum to "Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study" [J Hepatol 67 (2017) 940-949]. 630 S0168-8278(17)32532-1 10.1016/j.jhep.2017.12.017 Bureau Christophe C Service d'hépato

2018 Journal of Hepatology

12. Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study. (PubMed)

Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study. Refractory ascites (RA) is a complication of cirrhosis which is treated with large volume paracentesis (LVP) as the standard of care. Alfapump® system is a fully implantable pump system which reduces the need for LVP. The aim was to assess health-related quality of life

2018 Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

13. Better with Ultrasound: Paracentesis. (PubMed)

Better with Ultrasound: Paracentesis. Paracentesis is a commonly performed procedure and generally considered to be low risk. Despite its overall favorable safety profile, use of ultrasound has been demonstrated to reduce the incidence of complications, especially in higher risk patients. Many individual ultrasound techniques have been described in the literature, each with the goal of making paracentesis safer. This article presents a systematic approach for incorporating many of these tools

2018 Chest

14. Post-paracentesis hemoperitoneum - time to become more careful! (PubMed)

Post-paracentesis hemoperitoneum - time to become more careful! 29453898 2019 03 12 2019 03 12 1478-3231 38 9 2018 09 Liver international : official journal of the International Association for the Study of the Liver Liver Int. Post-paracentesis hemoperitoneum - Time to become more careful! 1698 10.1111/liv.13723 Satsangi Sandeep S 0000-0002-0013-7272 Department of Global Integrated Liver Care, B.G.S Gleneagles Global Hospital, Kengeri, Bangalore, India. eng Letter Comment 2018 03 14 United (...) States Liver Int 101160857 1478-3223 IM Liver Int. 2018 Aug;38(8):1437-1441 29393567 Liver Int. 2018 Sep;38(9):1698-1699 30145847 Acute Kidney Injury Hemoperitoneum Humans Liver Cirrhosis Paracentesis Sepsis 2018 2 18 6 0 2019 3 13 6 0 2018 2 18 6 0 ppublish 29453898 10.1111/liv.13723

2018 Liver International

15. The Role of Ultrasound-Guided Therapeutic Paracentesis in an Outpatient Transitional Care Program: A Case Series. (PubMed)

The Role of Ultrasound-Guided Therapeutic Paracentesis in an Outpatient Transitional Care Program: A Case Series. Patients with ascites suffer from distressing symptoms and are at high risk for readmission after hospitalization. Timely paracentesis is an important palliative tool in managing this vulnerable population. At our institution, we have developed a multidisciplinary transitional care program for patients discharged from the hospital with a wide range of complex conditions including (...) refractory ascites.We present a case series of 10 patients with symptomatic ascites who were enrolled in our transitional care program and treated with ultrasound-guided therapeutic paracentesis in our clinic. Patient medical records were retrospectively reviewed to collect procedure details, outcomes, and follow-up data on emergency department (ED) visits and readmissions. Cost data were obtained from the hospital financial system.Over the span of 9 months (September 2016 to July 2017), 22 total

2018 American Journal of Hospice and Palliative Medicine

16. Paracentesis in cirrhotics is associated with increased risk of 30-day readmission (PubMed)

Paracentesis in cirrhotics is associated with increased risk of 30-day readmission To determine the readmission rate, its reasons, predictors, and cost of 30-d readmission in patients with cirrhosis and ascites.A retrospective analysis of the nationwide readmission database (NRD) was performed during the calendar year 2013. All adults cirrhotics with a diagnosis of ascites, spontaneous bacterial peritonitis, or hepatic encephalopathy were identified by ICD-9 codes. Multivariate analysis (...) was performed to assess predictors of 30-d readmission and cost of readmission.Of the 59597 patients included in this study, 18319 (31%) were readmitted within 30 d. Majority (58%) of readmissions were for liver related reasons. Paracentesis was performed in 29832 (50%) patients on index admission. Independent predictors of 30-d readmission included age < 40 (OR: 1.39; CI: 1.19-1.64), age 40-64 (OR: 1.19; CI: 1.09-1.30), Medicaid (OR: 1.21; CI: 1.04-1.41) and Medicare coverage (OR: 1.13; CI: 1.02-1.26), > 3

Full Text available with Trip Pro

2018 World journal of hepatology

17. Large-volume paracentesis effects plasma disappearance rate of indo-cyanine green in critically ill patients with decompensated liver cirrhosis and intraabdominal hypertension (PubMed)

Large-volume paracentesis effects plasma disappearance rate of indo-cyanine green in critically ill patients with decompensated liver cirrhosis and intraabdominal hypertension Ascites is a major complication of decompensated liver cirrhosis. Intraabdominal hypertension and structural alterations of parenchyma involve decisive changes in hepatosplanchnic blood flow. Clearance of indo-cyanine green (ICG) is mainly dependent on hepatic perfusion and hepatocellular function. As a consequence (...) , plasma disappearance rate of ICG (ICG-PDR) is rated as a useful dynamic parameter of liver function. This study primarily evaluates the impact of large-volume paracentesis (LVP) on ICG-PDR in critically ill patients with decompensated cirrhosis. Additionally, it describes influences on intraabdominal pressure (IAP), abdominal perfusion pressure (APP), hepatic blood flow, hemodynamic and respiratory function.We analyzed LVP in 22 patients with decompensated liver cirrhosis. ICG-PDR was assessed

Full Text available with Trip Pro

2018 Annals of intensive care

18. Quality of Life of Patients Who Have Rocket Indwelling Pleural Catheter Drainage or Repeated Large Volume Paracentesis

Quality of Life of Patients Who Have Rocket Indwelling Pleural Catheter Drainage or Repeated Large Volume Paracentesis Quality of Life of Patients Who Have Rocket Indwelling Pleural Catheter Drainage or Repeated Large Volume Paracentesis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) number of saved studies (100). Please remove one or more studies before adding more. Quality of Life of Patients Who Have Rocket Indwelling Pleural Catheter Drainage or Repeated Large Volume Paracentesis The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details

2018 Clinical Trials

19. EUS-guided paracentesis and ascitic fluid analysis (PubMed)

EUS-guided paracentesis and ascitic fluid analysis 30117483 2018 11 14 2303-9027 7 4 2018 Jul-Aug Endoscopic ultrasound Endosc Ultrasound EUS-guided paracentesis and ascitic fluid analysis. 223-227 10.4103/eus.eus_31_18 Chin Matthew A MA Division of Gastroenterology, John Muir Specialty Medical Group, Walnut Creek, CA, USA. eng Journal Article China Endosc Ultrasound 101622292 2226-7190 There are no conflicts of interest 2018 8 18 6 0 2018 8 18 6 0 2018 8 18 6 1 ppublish 30117483

Full Text available with Trip Pro

2018 Endoscopic ultrasound

20. EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. (PubMed)

EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. To investigate the effect of serial anterior chamber (AC) paracenteses in eyes with sustained elevations of intraocular pressure (IOP) in the setting of repeated intravitreal injections (IVI) of anti-vascular endothelial growth factor medications.This is a retrospective records review of patients undergoing IVI of anti (...) -vascular endothelial growth factor medication (bevacizumab, ranubizumab, or aflibercept), who demonstrated a sustained elevation of preinjection IOP and also received AC paracentesis immediately after IVI on at least three consecutive visits. Changes in preinjection IOP and cup-to-disk (C:D) ratio were compared before and after the initiation of IVI and before and after the introduction of AC paracenteses with each subsequent IVI.Twenty-three eyes of 17 patients receiving a median of 26 IVI experienced

2018 Retina

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>